Lataa...
Strategies to Inhibit Myc and Their Clinical Applicability
Myc is an oncogene deregulated in most—perhaps all—human cancers. Each Myc family member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance. Myc is recognized as a “most wanted” target for cancer therapy, but has for many years been considered undruggable, mainly due to its...
Tallennettuna:
| Julkaisussa: | Front Cell Dev Biol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5322154/ https://ncbi.nlm.nih.gov/pubmed/28280720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2017.00010 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|